These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14742220)

  • 1. Ribosomal alterations contribute to bacterial resistance against the dipeptide antibiotic TAN 1057.
    Limburg E; Gahlmann R; Kroll HP; Beyer D
    Antimicrob Agents Chemother; 2004 Feb; 48(2):619-22. PubMed ID: 14742220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide antibiotic inhibition of translation and 50S ribosomal subunit assembly in methicillin-resistant Staphylococcus aureus cells.
    Champney WS; Burdine R
    Microb Drug Resist; 1998; 4(3):169-74. PubMed ID: 9818968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythromycin- and chloramphenicol-induced ribosomal assembly defects are secondary effects of protein synthesis inhibition.
    Siibak T; Peil L; Xiong L; Mankin A; Remme J; Tenson T
    Antimicrob Agents Chemother; 2009 Feb; 53(2):563-71. PubMed ID: 19029332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a novel antibacterial agent that inhibits bacterial translation.
    Böddeker N; Bahador G; Gibbs C; Mabery E; Wolf J; Xu L; Watson J
    RNA; 2002 Sep; 8(9):1120-8. PubMed ID: 12358431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of common rpsL mutations in Escherichia coli to sensitivity to ribosome targeting antibiotics.
    Pelchovich G; Schreiber R; Zhuravlev A; Gophna U
    Int J Med Microbiol; 2013 Dec; 303(8):558-62. PubMed ID: 23972615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 50S ribosomal subunit synthesis and translation are equivalent targets for erythromycin inhibition in Staphylococcus aureus.
    Champney WS; Burdine R
    Antimicrob Agents Chemother; 1996 May; 40(5):1301-3. PubMed ID: 8723490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAN-1057 A-D, new antibiotics with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. Taxonomy, fermentation and biological activity.
    Katayama N; Fukusumi S; Funabashi Y; Iwahi T; Ono H
    J Antibiot (Tokyo); 1993 Apr; 46(4):606-13. PubMed ID: 8501003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribosomes from an oxazolidinone-resistant mutant confer resistance to eperezolid in a Staphylococcus aureus cell-free transcription-translation assay.
    Murray RW; Schaadt RD; Zurenko GE; Marotti KR
    Antimicrob Agents Chemother; 1998 Apr; 42(4):947-50. PubMed ID: 9559817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evernimicin binds exclusively to the 50S ribosomal subunit and inhibits translation in cell-free systems derived from both gram-positive and gram-negative bacteria.
    McNicholas PM; Najarian DJ; Mann PA; Hesk D; Hare RS; Shaw KJ; Black TA
    Antimicrob Agents Chemother; 2000 May; 44(5):1121-6. PubMed ID: 10770739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides.
    Prunier AL; Malbruny B; Tandé D; Picard B; Leclercq R
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3054-6. PubMed ID: 12183270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exit tunnel modulation as resistance mechanism of S. aureus erythromycin resistant mutant.
    Halfon Y; Matzov D; Eyal Z; Bashan A; Zimmerman E; Kjeldgaard J; Ingmer H; Yonath A
    Sci Rep; 2019 Aug; 9(1):11460. PubMed ID: 31391518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin inhibits the assembly of the large ribosomal subunit in growing Escherichia coli cells.
    Chittum HS; Champney WS
    Curr Microbiol; 1995 May; 30(5):273-9. PubMed ID: 7766155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Expression of Antibiotic Resistance Methyltransferase Correlates with mRNA Stability Independently of Ribosome Stalling.
    Dzyubak E; Yap MN
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7178-7188. PubMed ID: 27645242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of erythromycin and clarithromycin against clinical isolates of Escherichia coli, Staphylococcus aureus, Klebsiella and Proteus by disc diffusion method.
    Khan NW; Hassan F; Naqvi BS; Hasan SM
    Pak J Pharm Sci; 2011 Jan; 24(1):25-9. PubMed ID: 21190914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cis-acting resistance peptides reveal dual ribosome inhibitory action of the macrolide josamycin.
    Lovmar M; Vimberg V; Lukk E; Nilsson K; Tenson T; Ehrenberg M
    Biochimie; 2009 Aug; 91(8):989-95. PubMed ID: 19463886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to antibiotics and alterations in the bacterial ribosome.
    Brakier-Gingras L
    Biomedicine; 1974 Jul; 21(7):267-72. PubMed ID: 4279706
    [No Abstract]   [Full Text] [Related]  

  • 17. An antibiotic preorganized for ribosomal binding overcomes antimicrobial resistance.
    Wu KJY; Tresco BIC; Ramkissoon A; Aleksandrova EV; Syroegin EA; See DNY; Liow P; Dittemore GA; Yu M; Testolin G; Mitcheltree MJ; Liu RY; Svetlov MS; Polikanov YS; Myers AG
    Science; 2024 Feb; 383(6684):721-726. PubMed ID: 38359125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug-resistance of staphylococcus aureus and detection of mecA gene in all strains isolated from children in Hangzhou].
    Hua CZ; Li JP; Yu HM; Li S; Ye H; Shang SQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):360-3. PubMed ID: 16780714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tools for characterizing bacterial protein synthesis inhibitors.
    Orelle C; Carlson S; Kaushal B; Almutairi MM; Liu H; Ochabowicz A; Quan S; Pham VC; Squires CL; Murphy BT; Mankin AS
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5994-6004. PubMed ID: 24041905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Staphylococcus aureus Strains Isolated from Czech Cystic Fibrosis Patients: High Rate of Ribosomal Mutation Conferring Resistance to MLS(B) Antibiotics as a Result of Long-Term and Low-Dose Azithromycin Treatment.
    Tkadlec J; Vařeková E; Pantůček R; Doškař J; Růžičková V; Botka T; Fila L; Melter O
    Microb Drug Resist; 2015 Aug; 21(4):416-23. PubMed ID: 25826283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.